CNR1 and schizophrenia: In addition, according to the cannabinoid hypothesis of schizophrenia, higher CB1R density or endocannabinoid levels are observed in schizophrenic patients in cortical and subcortical (limbic) structures (Müiller-Vahl and Emrich, 2008).